Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeneDx Holdings

98.47
+9.1510.24%
Post-market: 98.40-0.0700-0.07%19:18 EDT
Volume:915.50K
Turnover:90.20M
Market Cap:2.76B
PE:-50.64
High:101.35
Open:91.19
Low:90.20
Close:89.32
Loading ...

GeneDx ‘committing widespread fraud’ according to insiders, Grizzly says

TIPRANKS
·
05 Feb

GeneDx down 3% after Grizzly Research publishes short report, alleging fraud

TIPRANKS
·
05 Feb

BRIEF-Grizzly Research - We Are Short GeneDx

Reuters
·
05 Feb

Grizzly Research - We Are Short GeneDx

THOMSON REUTERS
·
05 Feb

Craig-Hallum Keeps Their Buy Rating on GeneDx Holdings (WGS)

TIPRANKS
·
28 Jan

Craig-Hallum Sticks to Its Buy Rating for GeneDx Holdings (WGS)

TIPRANKS
·
24 Jan

Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green

Simply Wall St.
·
20 Jan

Stock Track | GeneDx Holdings Stock Soars 5.47% in Pre-Market on Promising Product Pipeline Updates

Stock Track
·
15 Jan

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

Business Wire
·
15 Jan

Stock Track | GeneDx Holdings Plummets 9.41% Despite Upbeat Q4 Results

Stock Track
·
14 Jan

GeneDx raises Q4 adjusted gross margin view to 68% from 64%

TipRanks
·
14 Jan

Craig-Hallum Sticks to Its Buy Rating for GeneDx Holdings (WGS)

TIPRANKS
·
14 Jan

GeneDx Holdings Corp - Expects to Exceed Full Year 2024 Revenues Outlook of at Least $299 Million

THOMSON REUTERS
·
13 Jan

GeneDx Q4 Revenue USD 92 Million VS. Ibes Estimate USD 80.2 Million

THOMSON REUTERS
·
13 Jan

Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH

Business Wire
·
13 Jan

GeneDx Continues Its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

THOMSON REUTERS
·
08 Jan